Switzerland’s drugs regulator has decided to make permanent its participation in Project Orbis, the global initiative that allows simultaneous reviews of new cancer drugs by selected medicines agencies. Swissmedic has also published guidance explaining how the application and review process works.
Project Orbis was launched in September 2019 by the Oncology Center of Excellence of the US Food and Drug Administration...








